• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β淀粉样蛋白42作为阿尔茨海默病的生物标志物:唾液能否成为脑脊液的可行替代物?

Aβ42 as a Biomarker of Alzheimer's Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?

作者信息

Boschi Silvia, Roveta Fausto, Grassini Alberto, Marcinnò Andrea, Cermelli Aurora, Ferrandes Fabio, Rainero Innocenzo, Rubino Elisa

机构信息

Department of Neuroscience "Rita Levi Montalcini", University of Torino, 10126 Torino, Italy.

出版信息

Brain Sci. 2022 Dec 17;12(12):1729. doi: 10.3390/brainsci12121729.

DOI:10.3390/brainsci12121729
PMID:36552188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9775629/
Abstract

The identification of reliable biomarkers in biological fluids is paramount to optimizing the diagnosis of Alzheimer’s disease (AD). Measurement of Aβ42, t-tau, and p-tau in cerebrospinal fluid (CSF) is the most accepted method to support the diagnosis of AD. However, lumbar puncture represents an invasive investigation, whereas saliva is one of the most accessible body fluids. The aim of our study was to investigate salivary concentrations in AD and evaluate the correlation between salivary and CSF Aβ42 concentrations in AD patients, patients with non-AD dementias, and controls. We recruited 100 subjects: 18 AD patients, 64 patients with non-AD dementias, and 18 controls. The mean saliva Aβ42 concentrations in AD patients were higher than in controls (p < 0.001), and to patients with non-AD dementias (p = 0.001). A significant negative correlation between salivary and CSF Aβ42 concentrations was found in the overall group (r = −0.562, p < 0.001) and in non-AD patients (r = −0.443, p < 0.001). Salivary Aβ42 concentrations positively correlated with CSF t-tau (r = 0.321, p = 0.001) and p-tau (r = 0.297, p = 0.001). Our study showed that in AD patients’ saliva, Aβ42 concentrations are specifically increased, and we found an interesting negative correlation between CSF and salivary Aβ42 concentrations that warrants further investigation.

摘要

在生物体液中鉴定可靠的生物标志物对于优化阿尔茨海默病(AD)的诊断至关重要。测量脑脊液(CSF)中的Aβ42、总tau蛋白(t-tau)和磷酸化tau蛋白(p-tau)是支持AD诊断最被认可的方法。然而,腰椎穿刺是一种侵入性检查,而唾液是最容易获取的体液之一。我们研究的目的是调查AD患者的唾液浓度,并评估AD患者、非AD痴呆患者和对照组中唾液与脑脊液Aβ42浓度之间的相关性。我们招募了100名受试者:18名AD患者、64名非AD痴呆患者和18名对照组。AD患者的唾液Aβ42平均浓度高于对照组(p < 0.001),也高于非AD痴呆患者(p = 0.001)。在整个组(r = -0.562,p < 0.001)和非AD患者中(r = -0.443,p < 0.001)发现唾液和脑脊液Aβ42浓度之间存在显著负相关。唾液Aβ42浓度与脑脊液t-tau(r = 0.321,p = 0.001)和p-tau(r = 0.297,p = 0.001)呈正相关。我们的研究表明,AD患者的唾液中Aβ42浓度特异性升高,并且我们发现脑脊液和唾液Aβ42浓度之间存在有趣的负相关,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/0429e35a47e1/brainsci-12-01729-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/2be9c5e8d8d6/brainsci-12-01729-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/8a22b80bec53/brainsci-12-01729-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/85739fd696ea/brainsci-12-01729-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/0429e35a47e1/brainsci-12-01729-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/2be9c5e8d8d6/brainsci-12-01729-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/8a22b80bec53/brainsci-12-01729-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/85739fd696ea/brainsci-12-01729-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3cf/9775629/0429e35a47e1/brainsci-12-01729-g004a.jpg

相似文献

1
Aβ42 as a Biomarker of Alzheimer's Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?β淀粉样蛋白42作为阿尔茨海默病的生物标志物:唾液能否成为脑脊液的可行替代物?
Brain Sci. 2022 Dec 17;12(12):1729. doi: 10.3390/brainsci12121729.
2
Association of PTHrP levels in CSF with Alzheimer's disease biomarkers.脑脊液中甲状旁腺激素相关蛋白水平与阿尔茨海默病生物标志物的关联。
Clin Mass Spectrom. 2018 Oct 9;14 Pt B:124-129. doi: 10.1016/j.clinms.2018.10.001. eCollection 2019 Nov.
3
Cerebrospinal Fluid Alzheimer's Biomarkers and Neurofilament Light Profile of Idiopathic Normal Pressure Hydrocephalus in China: A PUMCH Cohort Study.中国特发性正常压力脑积水的脑脊液阿尔茨海默病生物标志物和神经丝轻链特征:一项北京协和医院队列研究
Neurodegener Dis. 2020;20(5-6):165-172. doi: 10.1159/000514052. Epub 2021 Jun 2.
4
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.在OPTIMA队列中,脑脊液生物标志物可将经尸检确诊的阿尔茨海默病与其他痴呆症及健康对照区分开来。
J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725.
5
Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease.利用血液中的微小RNA预测阿尔茨海默病患者脑脊液中的P- tau/Aβ42水平
BMC Med. 2021 Nov 15;19(1):264. doi: 10.1186/s12916-021-02142-x.
6
CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias.阿尔茨海默病和额颞叶痴呆中的脑脊液β淀粉样蛋白42(Aβ42)及Aβ42/Aβ40比值
Diagnostics (Basel). 2023 Feb 19;13(4):783. doi: 10.3390/diagnostics13040783.
7
Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer's Disease Diagnosis.全唾液和腺泡唾液作为阿尔茨海默病诊断生物标志物的研究。
Brain Sci. 2022 May 3;12(5):595. doi: 10.3390/brainsci12050595.
8
The Correlation Study between Plasma Aβ Proteins and Cerebrospinal Fluid Alzheimer's Disease Biomarkers.血浆Aβ蛋白与脑脊液阿尔茨海默病生物标志物的相关性研究
Dement Neurocogn Disord. 2016 Dec;15(4):122-128. doi: 10.12779/dnd.2016.15.4.122. Epub 2016 Dec 31.
9
Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.基于 Lumipulse 全自动免疫分析的阿尔茨海默病脑脊液生物标志物:与韩国人群中淀粉样蛋白-β PET 和手工免疫分析的一致性:韩国人群中通过 Lumipulse 测量的 CSF AD 生物标志物。
Alzheimers Res Ther. 2021 Jan 12;13(1):22. doi: 10.1186/s13195-020-00767-3.
10
Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.遗忘型轻度认知障碍或早期阿尔茨海默病患者脑脊液中β淀粉样蛋白1-43水平:一项为期2年的随访研究。
Front Aging Neurosci. 2016 Mar 1;8:30. doi: 10.3389/fnagi.2016.00030. eCollection 2016.

引用本文的文献

1
Periodontitis-induced neuroinflammation triggers IFITM3-Aβ axis to cause alzheimer's disease-like pathology and cognitive decline.牙周炎诱导的神经炎症触发IFITM3-Aβ轴,导致阿尔茨海默病样病理改变和认知衰退。
Alzheimers Res Ther. 2025 Jul 19;17(1):166. doi: 10.1186/s13195-025-01818-3.
2
Salivary levels of amyloid beta reflect brain amyloid beta burden in cognitively-normal older adults.认知功能正常的老年人唾液中β-淀粉样蛋白水平反映脑内β-淀粉样蛋白负荷。
J Prev Alzheimers Dis. 2025 Jun 9:100216. doi: 10.1016/j.tjpad.2025.100216.
3
Elevated levels of salivary interleukin-34 in patients suffering from Alzheimer's disease.

本文引用的文献

1
Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer's disease.通过Lumipulse检测阿尔茨海默病患者唾液中的tau蛋白和磷酸化tau-181蛋白。
Front Aging Neurosci. 2022 Sep 29;14:1014305. doi: 10.3389/fnagi.2022.1014305. eCollection 2022.
2
Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson.阿尔茨海默病和帕金森病患者唾液生物标志物的系统评价
Biomedicines. 2022 Jul 14;10(7):1702. doi: 10.3390/biomedicines10071702.
3
Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer's Disease Diagnosis.
阿尔茨海默病患者唾液中白细胞介素-34水平升高。
Clin Oral Investig. 2025 May 20;29(6):303. doi: 10.1007/s00784-025-06376-4.
4
An Update of Salivary Biomarkers for the Diagnosis of Alzheimer's Disease.用于阿尔茨海默病诊断的唾液生物标志物最新进展
Int J Mol Sci. 2025 Feb 26;26(5):2059. doi: 10.3390/ijms26052059.
5
Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.阿尔茨海默病研究中唾液生物标志物研究的分析前变量标准化指南:痴呆研究唾液生物标志物工作组的最新综述与共识
Alzheimers Dement. 2025 Feb;21(2):e14420. doi: 10.1002/alz.14420. Epub 2024 Dec 30.
6
Navigating the Alzheimer's Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics.探索阿尔茨海默病生物标志物领域:基于体液的诊断方法全面分析。
Cells. 2024 Nov 18;13(22):1901. doi: 10.3390/cells13221901.
7
Salivary biomarkers: The early diagnosis of Alzheimer's disease.唾液生物标志物:阿尔茨海默病的早期诊断
Aging Med (Milton). 2024 Feb 20;7(2):202-213. doi: 10.1002/agm2.12282. eCollection 2024 Apr.
8
Salivary Biomarkers for Alzheimer's Disease: A Systematic Review with Meta-Analysis.用于阿尔茨海默病的唾液生物标志物:系统评价与荟萃分析。
Int J Mol Sci. 2024 Jan 18;25(2):1168. doi: 10.3390/ijms25021168.
全唾液和腺泡唾液作为阿尔茨海默病诊断生物标志物的研究。
Brain Sci. 2022 May 3;12(5):595. doi: 10.3390/brainsci12050595.
4
Body Fluid Biomarkers for Alzheimer's Disease-An Up-To-Date Overview.阿尔茨海默病的体液生物标志物——最新综述
Biomedicines. 2020 Oct 15;8(10):421. doi: 10.3390/biomedicines8100421.
5
Salivary biomarkers in Alzheimer's disease.阿尔茨海默病的唾液生物标志物。
Clin Oral Investig. 2020 Oct;24(10):3437-3444. doi: 10.1007/s00784-020-03214-7. Epub 2020 Jan 27.
6
Salivary Biomarkers for Alzheimer's Disease and Related Disorders.用于阿尔茨海默病及相关疾病的唾液生物标志物
Neurol Ther. 2019 Dec;8(Suppl 2):83-94. doi: 10.1007/s40120-019-00168-1. Epub 2019 Dec 12.
7
Biomarkers for tau pathology.tau 病理学的生物标志物。
Mol Cell Neurosci. 2019 Jun;97:18-33. doi: 10.1016/j.mcn.2018.12.001. Epub 2018 Dec 7.
8
Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings.唾液中β淀粉样蛋白水平可检测,且能区分阿尔茨海默病痴呆患者与正常对照:初步研究结果。
BMC Neurol. 2018 Sep 26;18(1):155. doi: 10.1186/s12883-018-1160-y.
9
Salivary biomarkers for the diagnosis and monitoring of neurological diseases.唾液生物标志物用于神经疾病的诊断和监测。
Biomed J. 2018 Apr;41(2):63-87. doi: 10.1016/j.bj.2018.03.004. Epub 2018 May 10.
10
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.